C-Major is a medical technology company. It asserts that over 2 million people suffer a Needle Stick Injury (NSI) every year and are at risk of contracting blood-borne viruses such as Hepatitis and HIV. It aspires to resolve this crisis by bringing to market its patented medical device, Controlled Helical Retraction Device, to prevent NSIs. The company argues that the device contains a ‘Helical Track’ mechanism for controlled acceleration of the needle during retraction as well as a ‘Sealed Port’ to minimise any blood splatter. C-Major endeavours to disrupt the $5.5 billion safety syringe market with its product. It is backed by the UK 'Innovation Seed' fund. C-Major will use the investment to complete the final design of its product for manufacture and assembly ahead of a Series A funding round in 2021.
days to go:
Expired
investment:
£211,595
Anastasis Biotec (AB) is a company that is developing a human protein-based product, Syntana-4 (S-4), that inhibits Cancer Stem Cells (CSC) - the growth engine of cancer. The global cancer drug market was at ~$200 billion in 2019. S-4 will initially target use for patients with relapsed prostate cancer which caused 3.8% of global cancer deaths in 2018. The company asserts that S-4 will have low manufacturing costs, making it affordable, enabling ‘mass-market’ sales. AB has raised £450,000 in equity convertible loans and grants in 2019 & 2020, including an Innovate-UK award. It is also aiming to progress S-4 further in collaboration with the University of Chicago’s cancer stem cell therapeutics Research and development (R&D) program. The company will use the investment to complete lab-testing before starting clinical trials.
days to go:
Expired
investment:
£270,543
Cornish Lithium (CL) is a mineral exploration company engaged in the discovery of lithium and other battery metals in Cornwall. It intends to create a 'Battery Metals Hub' in the UK through its efforts. CL has received funding to build the first European Union (EU) pilot lithium extraction plant powered by geothermal waters. It asserts that some of the world's highest grades of lithium are found in geothermal waters. The company has also secured UK Government funding for a new lithium extraction pilot plant in Cornwall. CL has drilled 41 shallow boreholes in a former china clay pit near St Austell, demonstrating the potential to extract lithium from granite. The company will use the investment to accelerate the company towards commercial production of lithium.
days to go:
Expired
investment:
£5,199,999
Living With is a health technology company offering a pocket-friendly and simple patient management application that allows medical professionals treat and track patients remotely. The app aims to revolutionise the way doctors and hospitals access digital tools to treat patients while collecting data for medical device and pharma companies. The company owns Squeezy (a popular paid medical app in the UK) and already has five products in 17 NHS Trusts. Living With also has a contract with one of the world’s greatest medical device companies. Living With will use the proceeds to give 5 data (drug/device) and 50 access customers (clinic/doctor), become HIPAA compliant for the US and to quicken sales and marketing.
days to go:
Expired
investment:
£200,000
AdLaunch is an online video maker tool aimed at social media advertising creation. Using its patented AI-powered video generation technology, it enables businesses to create multiple high-quality videos, realtime previews and edit videos in the browser itself. This helps companies undertake online video advertising almost instantaneously within their respective budgets. AdLaunch has 11,000 users in over 130 countries worldwide. It has made 1.4 million pre-licensed HD videos and high-quality photos. The company aims to become synonymous with creating data-driven video ads and video campaigns. AdLaunch was awarded the 'Third Prize' at the Slush 100 pitch competition out of 2650 companies. it also secured three government R&D grants totaling £219,000 from the Business Finland - the Finnish Innovation Agency. AdLaunch is partnering with AppSumo which has a user base of 730,000 registered newsletter readers. With the proceeds, the company will develop its video generator and invest £8000 per month on Google, Facebook, and YouTube advertising to accelerate its customer acquisition.
days to go:
Expired
investment:
£85,278
MedicSpot is a healthcare company that is aiming to revolutionise healthcare delivery by combining the advantages of online and offline care. The company provides patients at designated hospitals with diagnostic tools like a stethoscope, oximeter, blood pressure monitor and thermometer which, in turn, is connected to the MedicSpot network. Onboard General Physicians (GPs) engage in live sessions with patients, guide them on how to use the tools, and perform a variety of diagnoses like listening to a patient’s heart and lungs, looking down their throat and into their ears, taking their blood pressure and oxygen readings, and measuring their body temperature. The company is also expanding into another subsidiary, Arc Health, which it claims will perform the aforementioned tasks with more efficiency and accuracy. The company will use the investment to increase the number of Medicspot clinics to 1,000, gain further NHS market share, launch a corporate business model and allow international pilots to take place.
days to go:
Expired
investment:
£1,048,396
Studio Pictures Limited is a UK based production company that specialises in the development of high-quality British film and TV projects. The company's interest predominantly lies within the British film and television industry that can be created within budget ranging from £1 million - £15 million. The company has established relationships with studio houses such as Warner Bros., Sony Pictures and Lionsgate and aims to build upon projects that can be made into a franchise. Their production, A Steet Cat Named Bob, went on to be distributed by Sony Pictures in the UK and had a Royal Premiere in London. Studio Pictures Limited will consider putting up to a maximum of 20% of the budget for each project as equity, on a case by case basis, subject to company reserves. With the proceeds, the company will grow and scale the business. It will become a tenant at Twickenham Studios in West London and look to profitable emerging markets, i.e. streaming, animation and interactive movies to become one of the leading UK production companies.
days to go:
Expired
investment:
Withheld
MacRebur uses waste plastics destined for landfill or incineration and adding them into asphalt for road construction and surfacing to extend and enhance the bitumen (fossil fuel) binder. It argues that its carefully selected plastics, taken from the waste stream, are added into roads to improve strength and durability, whilst reducing the quantity of the oil-based bitumen used in a traditional road construction mix. MacRebur asserts that with each km of road laid using its MR products, the company sustainably uses up the equivalent weight of 740,541 one-time-use plastic bags. MacRebur has completed road tests in numerous countries including the UK and Europe, Turkey, Australia, and Japan to name a few. It has also signed agreements with India, the USA, Chile, Estonia, Kuwait, New Zealand, Switzerland, Bahrain, Spain, and Malaysia. The company will use the investment to build its manufacturing plants in five strategic locations across the world.
days to go:
Expired
investment:
£3,055,740
Carnot is an engineering company that is developing biofuel and hydrogen-powered Carnot engines with the aim of reducing global CO2 levels by 13%. The company asserts that metal engines, unable to withstand fuel combustion temperatures, waste one-third of fuel energy to cooling & have operating efficiencies of only 30%. Carnot argues that its engines can bring operating efficiencies up to 70%, halving fuel costs. It also intends to develop clean, secure, and affordable global off-grid energy solutions and provide disruptive technologies that are both commercially viable and environmentally friendly. Carnot was awarded a £157,000 Innovate UK Grant to develop an energy access solution in Sub-Saharan Africa. It was also awarded a place on OGTC Tech X accelerator, in partnership with organisations like British Petrol (BP), Equinor, and KPMG with a £100,000 funding. The company will use the investment to bump up the maximum theoretical engine efficiency to ~85%.
days to go:
Expired
investment:
£307,911
Gravitricity is an energy technology company based in Edinburgh, London. Its patented technology is based on a simple principle: raising and lowering a heavy weight to store and release energy. The Gravitricity system suspends weights of 500 - 5000 tonnes in a deep shaft by several cables, each of which is engaged with a winch capable of lifting its share of the weight. Electrical power is then absorbed or generated by raising or lowering the weight. The technology has a 25+ year life with no cyclical degradation, has no parasitic loads, is cost-effective and can be installed anywhere including city-centres. The company has recently submitted its fifth patent application and has won a grant under InnovateUK's Energy Catalyst programme. It is working with winch partner Huisman Equipment BV and controls-partner ISC to build a 250kW Concept Demonstrator and design modular full-scale systems. With the funds received, Gravitricity will buffer for any COVID-related delay in energy requirements amidst the global economic downturn.
days to go:
Expired
investment:
£775,000
